GALACTIA GLAUCESCENS KUNTH - FABACEAE (LEGUMINOSAE): TECNOLOGÍA DE VANGUARDIA
DOI:
https://doi.org/10.56238/arev8n4-043Palabras clave:
Biotecnología, Fitoterapia, Galactia glaucescens, ToxicidadResumen
Galactia glaucescens Kunth es una especie nativa de América del Sur cuyo uso tradicional se asocia principalmente con propiedades antivenenosas. Estudios recientes han demostrado la capacidad de sus extractos para neutralizar las actividades neurotóxica y miotóxica de los venenos de serpiente, lo que refuerza su potencial farmacológico. Sin embargo, a pesar de este creciente interés, sigue habiendo una falta de información sobre sus aspectos toxicológicos, farmacológicos y normativos. Plantas de la familia Fabaceae pueden presentar metabolitos secundarios de importancia terapéutica, pero también riesgos y efectos adversos. Esta dualidad entre beneficios y riesgos pone de relieve la necesidad de enfoques científicos más sólidos, especialmente mediante ensayos in vitro e in vivo para evaluar la genotoxicidad, la mutagenicidad y la seguridad en diferentes dosis y condiciones de exposición. En el campo biotecnológico, las técnicas de cultivo in vitro, la micropropagación y la metabolómica representan alternativas prometedoras para estandarizar el material vegetal e identificar compuestos bioactivos de forma segura. Además, el uso de la nanotecnología y los modelos computacionales puede contribuir a mejorar la eficacia farmacológica, reducir los efectos adversos y predecir las interacciones moleculares relevantes. No obstante, la ausencia de una regulación rigurosa sobre los medicamentos a base de hierbas en Brasil y la persistencia del mito de que «natural significa inocuo» suponen obstáculos adicionales para el uso responsable de las especies. Se concluye que G. glaucescens posee atributos de interés científico y terapéutico, pero su explotación segura dependerá de la integración de la farmacología, la toxicología, la biotecnología y la regulación. Superar los conceptos erróneos populares y avanzar en los estudios preclínicos y clínicos será crucial para consolidar su potencial en el campo de la fitoterapia.
Descargas
Referencias
ATANASOV, Atanas G. et al. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov., v. 20, n. 3, p. 200–216, mar. 2021.
BARROS, Aiander Júnior Silva; SILVA, Kellen Lagares Ferreira; PORTO, Juliane Nancy de Lima. Anatomia e histoquímica de órgãos vegetativos de Galactia glaucescens (Kunth) (Leguminosae). DESAFIOS Rev. Interdiscip. Univ. Fed. Tocantins, v. 1, n. 1, p. 247–262, 2014. DOI: https://doi.org/10.20873/uft.2359-3652.2014v1n1p247
BENT, Stephen. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J. Gen. Intern. Med., v. 23, n. 6, p. 854–859, jun. 2008. DOI: https://doi.org/10.1007/s11606-008-0632-y
BEYRA MATOS, A.; HERRERA, P.; REYES, G.; HERNÁNDEZ, L. Revisión Taxonómica del Género Galactia P. Br. (Leguminosae-Papilionoideae) en Cuba. Rev. Acad. Colomb. Cienc., v. 29, n. 113, 467494, 2005. DOI: https://doi.org/10.18257/raccefyn.29(113).2005.2179
BISPO DOS SANTOS, J. O. Morfologia polínica de espécies de papiliodeae (Leguminosae) endêmicas da caatinga. Dissertação. Universidade do Estado da Bahia. 2014.
BRAVO-MONZÓN, Ángel E. et al. The Assembly of Tropical Dry Forest Tree Communities in Anthropogenic Landscapes: The Role of Chemical Defenses. Plants (Basel), v. 11, n. 4, p. 516, fev. 2022. DOI: https://doi.org/10.3390/plants11040516
BUTLER, Mark S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep., v. 25, n. 3, p. 475–516, jun. 2008. DOI: https://doi.org/10.1039/b514294f
CALIXTO, J. B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res., v. 33, n. 2, p. 179–189, fev. 2000. DOI: https://doi.org/10.1590/S0100-879X2000000200004
CAPASSO, Raffaele et al. Phytotherapy and quality of herbal medicines. Fitoterapia, v. 71, n. SUPPL. 1, p. S58–S65, ago. 2000. DOI: https://doi.org/10.1016/S0367-326X(00)00173-8
CARDOSO, Franciano Dias Pereira. Bioprospecção para compostos antimicobacterianos. 2017. 102f. Dissertação (Mestrado em Ciências do Ambiente) – Universidade Federal do Tocantins, Programa de Pós-Graduação em Ciências do Ambiente, Palmas, 2017.
CARVALHO, F. A. et al. Composição florística, riqueza e diversidade de um cerrado Sensu stricto no sudeste do estado de Goiás. Biosci. J., Uberlândia, v. 24, n. 4, p. 64-72, oct/dec 2008.
CEOLIN, Guilherme B.; MIOTTO, Silvia T. S. Synopsis of the genus Galactia (Phaseoleae, Papilionoideae, Leguminosae) in Brazil. Phytotaxa, v. 134, n. 1, p. 1-26, set. 2013. DOI: https://doi.org/10.11646/phytotaxa.134.1.1
CHAN, K. Some aspects of toxic contaminants in herbal medicines. Chemosphere, v. 52, n. 9, p. 1361–1371, set. 2003. DOI: https://doi.org/10.1016/S0045-6535(03)00471-5
CLEMENT, Charles R. et al. Origin and domestication of native Amazonian crops. Diversity (Basel), v. 2, n. 1, p. 72–106, jan. 2010. DOI: https://doi.org/10.3390/d2010072
CRUZ, Marina Sampaio de Menezes. Investigação da toxicidade genética de produtos naturais através de bioensaios de curta duração . 2015. 2775f. Dissertação (Mestrado em Bioquímica) - Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, 2015.
DAL BELO, C. A. et al. Antineurotoxic activity of Galactia glaucescens against Crotalus durissus terrificus venom. Fitoterapia, v. 79, n. 5, p. 378–380, jul. 2008. DOI: https://doi.org/10.1016/j.fitote.2008.04.003
DE ALBUQUERQUE, Ulysses Paulino et al. Medicinal and magic plants from a public market in northeastern Brazil. J. Ethnopharmacol., v. 110, n. 1, p. 76–91, 1 mar. 2007. DOI: https://doi.org/10.1016/j.jep.2006.09.010
DE SMET, Peter A. G. M. Herbal remedies. N. Engl. J. Med., v. 347, n. 25, p. 2046–2056, dez. 2002. DOI: https://doi.org/10.1056/NEJMra020398
DE SOUSA, C. A. O risco toxicológico do uso inadequado de plantas medicinais como alternativa terapêutica para tratamento de diabetes no Brasil. Rev. Multidisciplinar em Saúde, v. 4, n. 2, p. 1-6, 2023. DOI: https://doi.org/10.51161/inofarm/20399
DOS SANTOS, Márcio G. et al. New pharmacological insights of Galactia glaucescens. Nat. Prod. Res., v. 33, n. 16, p. 2389–2393, ago. 2019. DOI: https://doi.org/10.1080/14786419.2018.1443086
DUKE, Stephen O.; DAYAN, Franck E. Modes of action of microbially-produced phytotoxins. Toxins (Basel), v. 3, n. 8, p. 1038–1064, ago. 2011. DOI: https://doi.org/10.3390/toxins3081038
EFFERTH, Thomas; KOCH, Egon. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Targets, v. 12, n. 1, p. 122–132, jan. 2011. DOI: https://doi.org/10.2174/138945011793591626
EKOR, Martins. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol., v. 4, p. 177, jan. 2014. DOI: https://doi.org/10.3389/fphar.2013.00177
EUROPEAN MEDICINES AGENCY (EMA). Disponível em: <https://www.ema.europa.eu/en/genotoxicity-testing-data-interpretation-pharmaceuticals-intended-human-use.>. Acesso em: 22 fev. 2026.
EUROPEAN FOOD SAFETY AUTHORITY. Scientific Opinion on the re-evaluation of curcumin (E 100) as a food additive. EFSA Journal, v. 8, n. 9, p. 1679, 1 set. 2010. DOI: https://doi.org/10.2903/j.efsa.2010.1679
FAZILI, Mohammad Afaan et al. In vitro strategies for the enhancement of secondary metabolite production in plants: a review. Bull. Natl. Res. Cent., v. 46, n. 1, p. 35, fev. 2022. DOI: https://doi.org/10.1186/s42269-022-00717-z
FIRENZUOLI, Fabio; GORI, Luigi. Herbal medicine today: clinical and research issues. Evid. Based. Complement. Alternat. Med., v. 4, n. Suppl 1, p. 37–40, set. 2007. DOI: https://doi.org/10.1093/ecam/nem096
FUGH-BERMAN, A. Herb-drug interactions. Lancet, v. 355, n. 9198, p. 134–138, jan. 2000. DOI: https://doi.org/10.1016/S0140-6736(99)06457-0
Galactia glaucescens, Prefix Match - Plazi TreatmentBank. Disponível em: <https://treatment.plazi.org/GgServer/search?fullText.ftQuery=Galactia+glaucescen&fullText.matchMode=prefix&taxonomicName.taxonomicName=&taxonomicName.isNomenclature=true&taxonomicName.exactMatch=true&taxonomicName.order=&taxonomicName.family=&taxonomicName.genus=&taxonomicName.species=&BibMetaData.docAuthor=&BibMetaData.docDate=&BibMetaData.docTitle=&BibMetaData.docOrigin=&BibMetaData.part=&BibMetaData.pageNumber=&BibMetaData.extId=&materialsCitation.location=&materialsCitation.country=&materialsCitation.stateProvince=&materialsCitation.typeStatus=All+Types&materialsCitation.collectionCode=&materialsCitation.specimenCode=&materialsCitation.LSID=&materialsCitation.longitude=&materialsCitation.latitude=&materialsCitation.degreeCircle=1&materialsCitation.elevation=&materialsCitation.elevationCircle=100&indexName=0&subIndexName=0&minSubResultSize=0>. Acesso em: 22 fev. 2026.
Galactia glaucescens Kunth | Plants of the World Online | Kew Science. Disponível em: <https://powo.science.kew.org/taxon/urn%3Alsid%3Aipni.org%3Anames%3A495427-1?utm_source=chatgpt.com>. Acesso em: 23 fev. 2026.
GEORGIEV, Milen I. et al. Genetically transformed roots: from plant disease to biotechnological resource. Trends Biotechnol., v. 30, n. 10, p. 528–537, out. 2012. DOI: https://doi.org/10.1016/j.tibtech.2012.07.001
GOBBO-NETO, Leonardo; LOPES, Norberto P. Plantas medicinais: fatores de influência no conteúdo de metabólitos secundários. Quim. Nova, v. 30, n. 2, p. 374–381, abr. 2007. DOI: https://doi.org/10.1590/S0100-40422007000200026
GÓMEZ-MURILLO, P.; ARELLANO-MARTÍN, I. Plantas y serpientes: Una revisión de las plantas utilizadas popularmente como tratamiento antiofídico. Folia Botanica Extremadurensis, v. 15, p. 5-31, 2021.
HARTMANN, A. Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis, v. 18, n. 1, p. 45–51, jan. 2003. DOI: https://doi.org/10.1093/mutage/18.1.45
HUGHES JR, C. L. Phytochemical mimicry of reproductive hormones and modulation of herbivore fertility by phytoestrogens. Environ. Health Perspect., v. 78, p. 171–174, jun. 1988. DOI: https://doi.org/10.1289/ehp.8878171
IZZO, A. A.; ERNST, E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs, v. 61, n. 15, p. 2163–2175, 2001. DOI: https://doi.org/10.2165/00003495-200161150-00002
JOLY, A. B. Botânica: Introdução à taxonomia vegetal. 1a. ed. São Paulo: Companhia Editora Nacional, 2005.
JORDAN, Scott A.; CUNNINGHAM, David G.; MARLES, Robin J. Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol. Appl. Pharmacol., v. 243, n. 2, p. 198–216, mar. 2010. DOI: https://doi.org/10.1016/j.taap.2009.12.005
LEGISLAÇÃO. Disponível em: <https://semil.sp.gov.br/legislacao/2022/07/resolucao-sma-039-04/>. Acesso em: 23 fev. 2026.
LÓPEZ-LÁZARO, Miguel. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett., v. 252, n. 1, p. 1–8, jul. 2007. DOI: https://doi.org/10.1016/j.canlet.2006.10.029
MARTINS, Silvia et al. Bioactive phenolic compounds: production and extraction by solid-state fermentation. A review. Biotechnol. Adv., v. 29, n. 3, p. 365–373, maio 2011. DOI: https://doi.org/10.1016/j.biotechadv.2011.01.008
MATTEI, R.; DIAS, R. F.; ESPÍNOLA, E. B.; CARLINI, E. A.; BARROS, S. B. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidants activity in vitro. J. Ethnopharmacol., v; 60, n. 2, p. 111-116, mar 1998. DOI: https://doi.org/10.1016/S0378-8741(97)00141-4
NCBI TAXONOMY BROWSER. Disponível em: https://plantaedb.com/taxa/phylum/angiosperms/order/fabales/family/fabaceae/subfamily/papilionoideae/genus/galactia/species/galactia-glaucescens. Acesso em: 27 fev. 2026.
NEWMAN, David J.; CRAGG, Gordon M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod., v. 83, n. 3, p. 770–803, mar. 2020. DOI: https://doi.org/10.1021/acs.jnatprod.9b01285
PFUHLER, S. et al. Reduction of use of animals in regulatory genotoxicity testing: identification and implementation opportunities—report from an ECVAM workshop. Mutat. Res., v. 680, n. 1-2, p. 31-42, 2009. DOI: https://doi.org/10.1016/j.mrgentox.2009.09.002
PORTAL PLANTAS DO BRASIL. Disponivel em: https://www.portalplantasdobrasil.com.br/estado/sao-paulo/ Acesso em: 27 fev. 2026.
POSADZKI, Paul; WATSON, Leala K.; ERNST, Edzard. Adverse effects of herbal medicines: an overview of systematic reviews. Clin. Med., v. 13, n. 1, p. 7–12, fev. 2013. DOI: https://doi.org/10.7861/clinmedicine.13-1-7
POTT, A.; POTT, V. J. Plantas do Pantanal. Cad. Saúde Pública, v. 11, n. 4, dez. 1995, 320 p. DOI: https://doi.org/10.1590/S0102-311X1995000400015
PROGRAMA BIOTA-FAPESP. Disponível em: <https://bv.fapesp.br/linha-do-tempo/1234/programa-biota-fapesp/>. Acesso em: 23 fev. 2026.
RODRIGUES, Eliana; BARNES, Joanne. Pharmacovigilance of herbal medicines: the potential contributions of ethnobotanical and ethnopharmacological studies. Drug Saf., v. 36, n. 1, p. 1–12, jan. 2013. DOI: https://doi.org/10.1007/s40264-012-0005-7
ROUBIK, D.; MORENO, J. E. Pollen and Spores of Barro Colorado Island. 1991. 10.2307/4110734. DOI: https://doi.org/10.2307/4110734
SANTOS, M. G.; LOLIS, S. F.; DAL BELO, C. A. Levantamentos etnobotânicos realizados em duas comunidades de remanescentes de negros da região do jalapão, estado do Tocantins. In: PIRES, A. L. C. S. Sociabilidades negras, comunidades remanescentes, escravidão e cultura. 1. ed. Belo Horizonte : Gráfica Daliana, 2006.
SHAW, Debbie. Toxicological risks of Chinese herbs. Planta Med., v. 76, n. 17, p. 2012–2018, dez. 2010. DOI: https://doi.org/10.1055/s-0030-1250533
SINGH, Dev Bukhsh; PATHAK, Rajesh Kumar; RAI, Dipti. From Traditional Herbal Medicine to Rational Drug Discovery: Strategies, Challenges, and Future Perspectives. Rev. Bras. Farmacogn. v. 32, n. 2, p. 147–159, 18 fev. 2022. DOI: https://doi.org/10.1007/s43450-022-00235-z
SLIWOSKI, Gregory; KOTHIWALE, Sandeepkumar; MEILER, Jens; LOWE, Jr Edward W. Computational methods in drug discovery. Pharmacol. Rev., v. 66, n. 1, p. 334–395, 2014. DOI: https://doi.org/10.1124/pr.112.007336
SPRENT, J. I.; GEHLOT, H. S. Nodulated legumes in arid and semi-arid environments. Plant Ecology & Diversity, v. 3, n. 3, p. 211-219, 2010. DOI: https://doi.org/10.1080/17550874.2010.538740
SRINIVASAN, N. Exploring Advancements In Herbal-Nano Formulations: A Systematic Review. Asian J. Biol. Life Sci., v. 12, n. 1, p. 22-32, Jan-Apr, 2023. DOI: https://doi.org/10.5530/ajbls.2023.12.4
STICH, H. F.; ROSIN, M. P. Micronuclei in exfoliated human cells as a tool for studies in cancer risk and cancer intervention. Cancer Lett., v. 22, n. 3, p. 241-253, 1984. DOI: https://doi.org/10.1016/0304-3835(84)90159-9
STREET, R. A. Heavy metals in medicinal plant products — An African perspective. S. Afr. J. Bot., v. 82, p. 67–74, set. 2012. DOI: https://doi.org/10.1016/j.sajb.2012.07.013
SUMEDH, M. V. et al. A review on herbs against snake venom. Jour. Pharmacog. & Phytochem., v. 7, n. 6, p. 5-9. 2018. DOI: https://doi.org/10.22271/phyto.2018.v7.isp6.1.02
SUSILAWATI, Elis et al. Pharmacology activity, toxicity, and clinical trials of Erythrina genus plants (Fabaceae): an evidence-based review. Front. Pharmacol., v. 14, p. 1281150, nov. 2023. DOI: https://doi.org/10.3389/fphar.2023.1281150
TILBURT, Jon. Herbal medicine research and global health: an ethical analysis. Bull. World Health Organ., v. 86, n. 8, p. 594–599, ago. 2008. DOI: https://doi.org/10.2471/BLT.07.042820
VEASEY, E. A. et al. Avaliação de caracteres morfológicos e agronômicos em leguminosas forrageiras tropicais visando a produção de sementes. B. Indústr. Anim., v. 56, n. 2, p. 109-125, 1999.
VEIGA JUNIOR, Valdir F.; PINTO, Angelo C.; MACIEL, Maria Aparecida M. Plantas medicinais: cura segura? Quim. Nova, v. 28, n. 3, p. 519–528, jun. 2005. DOI: https://doi.org/10.1590/S0100-40422005000300026
WAGNER, H.; ULRICH-MERZENICH, G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine, v. 16, n. 2–3, p. 97–110, mar. 2009. DOI: https://doi.org/10.1016/j.phymed.2008.12.018
WILLIAMSON, Elizabeth M. Drug interactions between herbal and prescription medicines. Drug Saf., v. 26, n. 15, p. 1075–1092, 2003. DOI: https://doi.org/10.2165/00002018-200326150-00002
WINK, M. Evolution of secondary metabolites in legumes (Fabaceae). S. Afr. J. Bot., v. 89, p. 164–175, nov. 2013. DOI: https://doi.org/10.1016/j.sajb.2013.06.006
WOLFENDER, Jean-Luc et al. Current approaches and challenges for the metabolite profiling of complex natural extracts. J. Chromatogr. A, v. 1382, p. 136–164, fev. 2015. DOI: https://doi.org/10.1016/j.chroma.2014.10.091
WORLD HEALTH ORGANIZATION. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. 2007.
